Percutaneous medicine administration kit, medicated, single-use

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
19-11-2017

제공처:

Janssen-Cilag Pty Ltd

수업:

Class IIa

Manufactured by:

Cilag AG Hochstrasse 201, SCHAFFHAUSEN, CH8200 Switzerland

치료 영역:

45156 - Medicine administration kit, percutaneous, medicated, single-use

치료 징후:

A kit for the intramuscular administration of the medicine Risperdal Consta. Kit includes the medicine Risperdal Consta; a prefilled syringe containing a dilutent; one needle-free vial access device; two needles with needle protection devices (21g for deltoid administration and a 20g for gluteal administration).

승인 상태:

A

승인 날짜:

2006-04-07

이 제품과 관련된 검색 알림